cardiology
A Difficult Act—Balancing Heart Health and Treating RA
Guidelines from the American College of Rheumatology recommend that clinicians treating rheumatoid arthritis with ...
FEBRUARY 9, 2025

Pharmacists Key Players on AFib Treatment Teams
Pharmacists are crucial, but often overlooked and underrepresented, members of the care team for patients with ...
NOVEMBER 12, 2024

Heart Rhythm Monitoring Tools Helpful When Used Judiciously
Pharmacists, nurse practitioners and physician assistants are all essential to helping patients understand ECG data ...
OCTOBER 2, 2024

Patients With ALD Have Lower Statin Uptake After Myocardial Infarction
Post–myocardial infarction patients are less likely to receive statins as part of their treatment if they ...
APRIL 2, 2024

Cardio-Oncology Yields Opportunities For Patient-Centered Care
Oncology pharmacists should collaborate with cardiologists and patients to navigate the cardiovascular risks of ...
MARCH 19, 2024

Appropriate Statin Use Soars When Pharmacists on Board
The odds of prescribing the appropriate dose of statins increased sixfold when automated referrals were made to ...
MARCH 14, 2024

Taking Pharmacogenomics Guidelines to Heart
Pharmacogenomics is a rapidly expanding field with new evidence and implications for cardiology practice, experts ...
FEBRUARY 23, 2024

AHA Recommends Oral Penicillin, Not Injectable, for Some Rheumatic Heart Disease Patients
A growing body of evidence indicates that some people may have experienced a cardiac reaction to the injectable ...
JANUARY 20, 2022

Novel Agent for HF Shows Mixed Results in Large Trial
The novel selective cardiac myosin activator omecamtiv mecarbil reduced a composite of a HF event or death from ...
JULY 22, 2021

IV Ferric Agent a Potent Addition to HF Therapy
Adding IV ferric carboxymaltose to traditional standard therapy can improve outcomes for patients with HF with ...
JULY 22, 2021

Polypill Reduces Cardiovascular Risk
Daily use of a polypill composed of a statin, a beta-blocker, an angiotensin-converting enzyme inhibitor and ...
MAY 25, 2021

Reduced Prasugrel Doses Associated With Lower Bleeding Risk in Some Heart Patients
A reduced dose of the antiplatelet prasugrel was as effective and safe as a standard dose of ticagrelor for certain ...
JULY 28, 2020
